Showing results (171-180 of 251) with videos related to
Sort By:
Pageof 26
The American Journal of Psychiatry|October 13, 1999
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophreniaC M Adler, A K Malhotra, I Elman, et al.Archives of General Psychiatry|November 1, 1988
Early parental loss and development of adult psychopathologyA Breier, J R Kelsoe, P D Kirwin, et al.Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteersA K Malhotra, D A Pinals, H Weingartner, et al.The American Journal of Psychiatry|January 1, 1994
Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaA Breier, R W Buchanan, B Kirkpatrick, et al.Science (New York, N.Y.)|May 3, 2014
Sulfur oxidation genes in diverse deep-sea virusesKarthik Anantharaman, Melissa B Duhaime, John A Breier, et al.The American Journal of Psychiatry|December 1, 1987
Neuroleptic responsivity of negative and positive symptoms in schizophreniaA Breier, O M Wolkowitz, A R Doran, et al.Archives of General Psychiatry|February 1, 1987
Clinical and biochemical effects of verapamil administration to schizophrenic patientsD Pickar, O M Wolkowitz, A R Doran, et al.Psychoneuroendocrinology|January 1, 1990
Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humansO M Wolkowitz, N M Papadopoulos, R Costello, et al.The American Journal of Psychiatry|January 1, 1993
Structural abnormalities in deficit and nondeficit schizophreniaR W Buchanan, A Breier, B Kirkpatrick, et al.Pageof 26